These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29941300)

  • 21. Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer.
    O'Donnell HE; Finnegan K; Eliades H; Oliveros S; Plowman PN
    Br J Radiol; 2008 Apr; 81(964):327-32. PubMed ID: 18344276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
    Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.
    Ost P; Speleers B; De Meerleer G; De Neve W; Fonteyne V; Villeirs G; De Gersem W
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):920-6. PubMed ID: 20675077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bladder dose accumulation based on a biomechanical deformable image registration algorithm in volumetric modulated arc therapy for prostate cancer.
    Andersen ES; Muren LP; Sørensen TS; Noe KO; Thor M; Petersen JB; Høyer M; Bentzen L; Tanderup K
    Phys Med Biol; 2012 Nov; 57(21):7089-100. PubMed ID: 23051686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
    Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
    Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical aspects of inverse-planned intensity-modulated radiation therapy for prostate cancer: a radiation treatment planner's perspective.
    Parker W; Patrocinio H
    Can J Urol; 2005 Jun; 12 Suppl 2():48-52. PubMed ID: 16018834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting rectal and bladder overdose during the course of prostate radiotherapy using dose-volume data from initial treatment fractions.
    Murthy V; Shukla P; Adurkar P; Master Z; Mahantshetty U; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):119-24. PubMed ID: 22300567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Curative radiotherapy of localized prostate cancer. Treatment methods and results].
    Schwarz R
    Urologe A; 2003 Sep; 42(9):1212-20. PubMed ID: 14504754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A quantitative study of IMRT delivery effects in commercial planning systems for the case of oesophagus and prostate tumours.
    Seco J; Clark CH; Evans PM; Webb S
    Br J Radiol; 2006 May; 79(941):401-8. PubMed ID: 16632620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
    Qin A; Sun Y; Liang J; Yan D
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer.
    Aillères N; Azria D; Thézenas S; Barbier N; Fenoglietto P; Delard R; Hay MH; Dubois JB
    Cancer Radiother; 2004 Apr; 8(2):59-69. PubMed ID: 15063872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interfraction Anatomical Variability Can Lead to Significantly Increased Rectal Dose for Patients Undergoing Stereotactic Body Radiotherapy for Prostate Cancer.
    Wahl M; Descovich M; Shugard E; Pinnaduwage D; Sudhyadhom A; Chang A; Roach M; Gottschalk A; Chen J
    Technol Cancer Res Treat; 2017 Apr; 16(2):178-187. PubMed ID: 27199276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of dose compensation in image-guided radiotherapy of prostate cancer.
    Wu Q; Liang J; Yan D
    Phys Med Biol; 2006 Mar; 51(6):1405-19. PubMed ID: 16510952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IMRT to escalate the dose to the prostate while treating the pelvic nodes.
    Cavey ML; Bayouth JE; Colman M; Endres EJ; Sanguineti G
    Strahlenther Onkol; 2005 Jul; 181(7):431-41. PubMed ID: 15995836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
    Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes.
    Mohan R; Zhang X; Wang H; Kang Y; Wang X; Liu H; Ang KK; Kuban D; Dong L
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1258-66. PubMed ID: 15752908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testicular doses in image-guided radiotherapy of prostate cancer.
    Deng J; Chen Z; Yu JB; Roberts KB; Peschel RE; Nath R
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e39-47. PubMed ID: 21489702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Dose Deformation-Invariance Hypothesis Verified in Prostate IGRT?
    Simon A; Le Maitre A; Nassef M; Rigaud B; Castelli J; Acosta O; Haigron P; Lafond C; de Crevoisier R
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):830-838. PubMed ID: 28244420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.